Reid M Huber
CIK 1607052 · EVP, Chief Scientific Officer · last filed 2026-06-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.40M
Companies
5
Total Filings
47
Lifetime Open-Market Net
-$9.12M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RAPP | Director | 20,400 | $41.94 | $855.6K | $499.4K | 3 | 2026-06-10 |
| CARGO Therapeutics, Inc. (CRGX) Delisted | Director | — | $4.47 | — | $0 | 4 | 2025-08-19 |
| TNGX | Director | 5,000 | $26.50 | $132.5K | $0 | 2 | 2023-06-08 |
| BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted | Director | 146,951 | $0.07 | $11.0K | $0 | 13 | 2023-01-20 |
| INCY | EVP, Chief Scientific Officer | 34,571 | $127.54 | $4.41M | -$9.61M | 25 | 2018-07-18 |
Recent Filings · Page 5 of 5
47 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-08-10 | INCY | Exer (M) | +8,397 | $150.5K | EDGAR |
| 2015-06-19 | BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-04-17 | INCY | Exer (M) | +10,060 | $148.3K | EDGAR |
| 2015-04-01 | INCY | Mixed | — | -$2.59M | EDGAR |
| 2015-01-09 | INCY | Grant (A) | +3,022 | $0 | EDGAR |
| 2014-12-03 | INCY | Exer (M) | +6,494 | $61.1K | EDGAR |
| 2014-11-14 | INCY | Exer (M) | +17,960 | $112.0K | EDGAR |
Showing 41–47 of 47
Prev
Page 5 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.